Pancreatic adenocarcinoma (PDAC) is the most frequent histological type of malignancy in the pancreas. Extracellular matrix (ECM), plays a critical role during the process of human carcinogenesis and the possible diversity in matricellular proteins composition of ECM may have a significant impact on the clinical course of PDAC. Aim of this paper was to evaluate the expression of three matricellular proteins, including Periostin (POSTN), Tenascin (TNS) and Osteopontin (OPN), in PDAC from long-survival (LS) and non-long survival (NLS) patients. A total of 30 PDAC were analyzed, 15 from patients that survived more than 60 months after surgery (LS) and 15 that died from the disease within 24 (NLS). RNA was extracted and OPN, TNS and POSTN mRNA levels were evaluated by qRT-PCR. LS and NLS samples showed the same type of POSTN and TN isoforms. On the contrary, OPN seems to be preferentially expressed in NLS PDAC. Moreover, OPNb and OPNc isoforms were expressed exclusively in NLS samples. In conclusion, Our data led to hypothesize a possible relationship between the expression of different isoforms of each of these proteins and the clinical outcome of patients with PDAC.
Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study / Fiorino, S.; Visani, M.; Masetti, M.; Acquaviva, G.; Tallini, G.; De Leo, A.; Fornelli, A.; Ragazzi, M.; Vasuri, F.; Grifoni, D.; Argento, C. M.; Maloberti, T.; Ravaioli, M.; Fabbri, C.; Jovine, E.; Pession, A.; de Biase, D.. - In: MOLECULAR BIOLOGY REPORTS. - ISSN 0301-4851. - 47:10(2020), pp. 8235-8241. [10.1007/s11033-020-05763-2]